From Infection to Frailty: How Survival Rewrites Hospice

For most of human history, death came quick. Today, it lingers.

Infections gave way to chronic disease and frailty. In high-income countries, ischemic heart disease, stroke, and dementias are now among the leading causes of death (World Health Organization [WHO], 2024).

Survival changed dying. Now functional decline defines hospice.

In 1900, U.S. life expectancy was about 47 years. Pneumonia and influenza, tuberculosis, and diarrheal illness were leading causes of death (CDC, 1999). Families knew dying. Doctors stood helpless.

Modern hospice had not yet emerged. Death often came too fast for prolonged care planning.

Science extended life but left decline in its place.

Antibiotics stopped once-fatal infections. Vaccines reshaped childhood survival. Cardiac cath labs and statins cut heart attack deaths. ICUs pulled patients back.

From 1970 to 2022, age-adjusted acute myocardial infarction mortality fell 89%, while heart failure mortality rose 146% (King et al., 2025). A heart attack may not kill, but it can scar, weaken, and leave decline.

The legacy of survival is frailty.

In high-income countries, sudden infectious death is less common. Decline dominates.

Circulatory and neurovascular conditions accounted for 55% of Medicare hospice stays in 2024 (National Alliance for Care at Home, 2026). Multimorbidity is common near the end of life (Aldridge & Bradley, 2017).

Frailty is a progressive loss of strength, endurance, and reserve.

A patient once told me, “I feel like I’m dissolving.” No one can say with certainty how long it lasts or how heavy it gets.

This is the modern end of life: slow, unpredictable, and costly.

Hospice rose from medicine’s victories. It wasn’t built for infection. It steadied decline and focused comfort. See The Shape of Dying for illness trajectories and their impact.

Hospice followed where medicine left patients.

As life expectancy shifts, so does hospice care and expectations.

The shift from infection to chronic illness changed who benefits most from hospice. Patients now live with unpredictable decline and heavy symptom burden. As disease advances, treatment burdens may outweigh benefits (Aldridge & Bradley, 2017; Chuzi et al., 2025).

Medicare hospice eligibility requires a physician to certify a life expectancy of six months or less if the terminal illness runs its normal course. This may be easier to recognize in some cancers than in dementia or a frailty trajectory. Prognostic tools support judgment. Some Medicare Administrative Contractor policies list repeated hospitalizations, functional decline, and progressive unintentional weight loss as supporting findings, not stand-alone eligibility rules (CMS, 2026a; CMS, 2026b).

Patterns that should trigger timely hospice evaluation include:

Advanced heart failure with refractory symptoms and frequent admissions (Heidenreich et al., 2022; Chuzi et al., 2025)

Stroke with severe disability (CMS, 2026b)

Advanced dementia with immobility, minimal speech, incontinence, infections, and weight loss (CMS, 2026b)

Frailty with exhaustion, weakness, inactivity, weight loss, and ADL dependence (CMS, 2026b)

Across these patterns, functional loss is a key prognostic signal. See PPS in Hospice for scoring decline.

In advanced heart failure, interdisciplinary palliative care can improve quality of life, anxiety, depression, and spiritual well-being. In a matched Medicare cohort, hospice enrollment was associated with fewer emergency visits, hospital days, and ICU stays, as well as modestly longer median survival (Rogers et al., 2017; Gelfman et al., 2018).

Yet clinicians still delay. Many expect a cancer-style trajectory of decline. Heart-failure guidelines and consensus recommendations support timely hospice referral and earlier integration of palliative care (Heidenreich et al., 2022; Chuzi et al., 2025). The system must catch up to reality.

Mr. Henry was 84. He survived a heart attack, then a stroke. Over three years, he stopped walking to the mailbox, began forgetting lunch, and fell again. His daughter took FMLA leave twice to bolster care, but the hospice referral still came late. He died 36 days after admission.

This is the habit of medicine from the past. We still look for slow and steady decline.

Data sharpens this point:

Hospice use: 70.8% of cancer deaths vs. 45.4% of noncancer deaths (Cagle et al., 2020)

Median completed Medicare hospice stay: 21 days in 2024 (National Alliance for Care at Home, 2026)

The six-month prognosis is harder to judge when frailty declines through plateaus and sudden setbacks. That uncertainty can delay referral.

What’s Important Now?

Document function (PPS, ADLs, and FAST when Alzheimer disease is present). Focus on the trajectory and the story.

Teach frailty literacy in IDG so we recognize a pattern before a crisis.

Forecast decline (Two-Minute Forecast). Clarify expectations with the family.

If we miss the current shape of dying, patients lose relief, families lose trust, and teams lose defensibility. Delay adds suffering. Missed signals trigger crisis care.

We cannot leave the middle unattended.